Neovascularization in human coronary arteries with lesions of different severity;Neovascularización en arterias coronarias humanas con distintos grados de lesión

Revista Espanola de Cardiologia

Volumn 56, Issue 10, 2003, Pages 978-986

  Juan Babot, Josep O ^a   Martinez González, José ^a   Berrospe, María ^a   Badimon, Lina ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Angiogenesis; Atherosclerosis; Smooth muscle cell; VEGF

Indexed keywords

CELL MARKER; PROTHROMBIN; THROMBIN; VASCULOTROPIN;

ADULT; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LIPID STORAGE; MACROPHAGE; MALE; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER;

EID: 0242438697     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13052386     Document Type: Article

References (41)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part I. N Engl J Med 1992;326:242-50.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part II. N Engl J Med 1992;326:310-8.
3. Gurfinkel EP. Infección y aterosclerosis. Rev Esp Cardiol 2001;54:383-92.
4. Sánchez-Recalde A, Kaski JC. Diabetes mellitus, inflamación y aterosclerosis coronaria: perspectiva actual y futura. Rev Esp Cardiol 2001;54:751-63.
5. Navarro-López F. Bases genéticas de la enfermedad coronaria. Rev Esp Cardiol 2002;55:413-31.
6. Patterson C. Temas actuales en biología vascular: puesta al día para el siglo XXI. Rev Esp Cardiol 2002;54:635-42.
7. Badimon L, Martínez-González J. Alteraciones funcionales y estructurales del endotelio en la aterosclerosis. En: Aranda P, Coca A, Palma JL, Plaza L, editores. Hipertensión y medicina cardiovascular. Madrid: Scientific Communication Manegement, 2001; p. 127-49.
8. Badimon L, Martínez-Gonzílez J. Endotelio en la protección vascular: nuevos conocimientos. Rev Esp Cardiol 2002:55:17-26.
9. Martínez-González J, Llorente-Cortés V, Badimon L. Biología celular y molecular de las lesiones ateroscleróticas. Rev Esp Cardiol 2001;54:218-31.
10. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001;49:507-21.
11. Giordano FJ. Angiogenesis: mechanisms, modulation, and targeted imaging. J Nucl Cardiol 1999;6:664-71.
12. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-52.
13. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 1995;77:638-43.
14. Chen YX, Nakashima Y, Tanaka K, Shiraishi S, Nakagawa K, Sueishi K. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler Thromb Vasc Biol 1999;19:131-9.
15. Inoue M, Itoh H, Ueda M, Naruko T,Kojima A, Komatsu R, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions. Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998;98:2108-16.
16. Kuzuya M, Satake S, Esaki T, Yamada K, Hayashi T, Naito M, et al. Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque. J Cell Physiol 1995;164:658-67.
17. Bar-Shavit R, Eldor A, Vlodavsky Y. Binding of thrombin to subendothelial extracellular matrix: protection and expression of functional properties. J Clin Invest 1989;84:1096-104.
18. Bradbury P, Gordon KC. Connective tissues and stains. En: Bancroft JD, Stevens A, editors. Theory and practice of histological techniques. 3rd ed. New York: Churchill Livingstone, 1990; p. 119-42.
19. Bayliss OB. Lipids. En: Bancroft JD, Stevens A, editors. Theory and practice of histological techniques. 3rd ed. New York: Churchill Livingstone, 1990; p. 215-44.
20. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Archiv a Pathol Anat Histopathol 1992; 421:277-90.
21. irmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death. A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.
22. Mason DY, Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol 1978;31:454-60.
23. Guesdon JL, Terynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979;27:1131-9.
24. Marriot D, Carlton SJ. Immunofluorescent techniques. En: Bancroft JD, Stevens A, editors. Theory and practice of histological techniques. 3rd ed. New York: Churchill Livingstone, 1990; p. 451-63.
25. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol 1990; 66:562-7.
26. McGill HC, McMahan CA, Zieske AW, Tracy RE, Malcom GT, Herderick EE, et al. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 2000;102:374-9.
27. Celletti FL, Hilfiker PR, Ghafouri P, Dake MD. Effect of human recombinant vascular endothelial growth factor 165 on progression of atherosclerotic plaque. J Am Coll Cardiol 2001;37; 2126-30.
28. Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am Journal Pathol 1993;143:164-72.
29. Jeziorska M, Woolley DE. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries. J Pathol 1999;188:189-96.
30. De Boer OJ, Van der Wal A, Teeling P, Becker AE. Leucocyte recruitment in rupture pronr regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res 1999;41: 443-9.
31. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181:902-6.
32. Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997;150:1673-85.
33. Ramos MA, Kuzuya M, Esaki T, Miura S, Satake S, Asai T, et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1998;18:1188-96.
34. Carson FL. Histotechnology: a self-instructional text. Chicago: ASCP Press, 1990; p. 236-7.
35. Haralabopoulos GC, Grant DS, Kleinman HK, Maragoudakis ME. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol 1997;273: C239-45.
36. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998; 75:780-6.
37. Zucker S, Conner C, DiMassimo BI, Ende H, Drews M, Seiki M, et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells physiologic regulation of angiogenesis. J Biol Chem 1995;270:23730-8.
38. Duhamel-Clerin E, Orvain C, Lanza F, Cazenave JP, Klein-Soyer C. Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. Arterioscler Thromb Vas Biol 1997;17:1931-8.
39. Herbert JM, Dupuy E, Laplace MC, Zini JM, Bar-Shavit R, Tobelem G. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem J 1994;303: 227-31.
40. Varela O, Martínez-González J, Badimon L. The response of smooth muscle cells to alpha-thrombin depends on its arterial origin: comparison among different species. Eur J Clin Invest 1998; 28:313-23.
41. Benezra M Vlodavsky I, Ishai-Michaeli R, Neufeld G, Bar-shavit R. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 1993;81:3324-31.